| 英文别名 |
1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine,9,13b-dihydro-, hydrochloride (1:1);Epinastine Hydrochloride;3-Amino-9,13b-Dihydro-1H-Dibenzo[c,f]Imidazo[1,5-a]Azepine Hydrochloride;Epinastine HCl;1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine,9,13b-dihydro-,h;9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride,WAL-801Cl;EPIMEDIUM P.E;EPINASTIN HCL;Epinastine;9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride;WAL-801Cl;Asmot;Elestat;Alesion;Azusaleon;WAL-801CL HCl;Epinastini Hydrochloride;Epinastine monohydrochloride;WAL 801 CL;WAL 801CL;Epinastine hydrochloride [JAN];Relestat;DSSTox_RID_81671;DSSTox_CID_26502;DSSTox_GSID_46502;C16H16ClN3;Epinastine hydrochloride (JAN);9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine Hydr;9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochlo;WAL801 hydrochloride;GFM415S5XL;Q27122286;MFCD00933434;CAS-108929-04-0;SCHEMBL122749;SW220223-1;EPINASTINE HYDROCHLORIDE [MI];Epinastine hydrochloride, European Pharmacopoeia (EP) Reference Standard;EN300-7365601;108929-04-0;DTXSID1046502;epinastin hydrochloride;s4253;DTXCID9026502;DE-114;LP00501;2,4-Diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydron;chloride;Flurinol;HMS3885B15;1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-,hydrochloride;Elestat (TN);CS-0013220;Tox21_112263_1;E0799;80012-44-8;EPINASTINE HYDROCHLORIDE [MART.];Epinastine hydrochloride, United States Pharmacopeia (USP) Reference Standard;EPINASTINE HYDROCHLORIDE [EP MONOGRAPH];AKOS015967222;BCP12119;HY-B0640A;UNII-GFM415S5XL;3-AMINO-9,13B-DIHYDRO-1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPINE HYDROCHLORIDE, DL-;EPINASTINE HYDROCHLORIDE [USP-RS];Z2756516876;3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine monohydrochloride;EPINASTINE HYDROCHLORIDE (MART.);WAL-802-CL;2,4-diazatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine hydrochloride;VKXSGUIOOQPGAF-UHFFFAOYSA-N;9,13b-Dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride;Epinastine hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard;FT-0700527;NCGC00261186-01;NCGC00165791-04;Epinastine for system suitability;F17420;J-002209;AC-1491;1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPIN-3-AMINE, 9,13B-DIHYDRO-, HYDROCHLORIDE (1:1);KS-1159;FT-0631049;9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride;Tox21_112263;Tox21_500501;CHEBI:51037;A857231;Epinastine hydrochloride, >=98% (HPLC), solid;CHEMBL1200491;IH-Dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, monohydrochloride;EPINASTINE HYDROCHLORIDE (EP MONOGRAPH);EPINASTINE HYDROCHLORIDE [WHO-DD];WAL801;Alesion (TN);EPINASTINE HYDROCHLORIDE (USP-RS);(13bRS)-9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride; 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-, monohydrochloride (9CI); Alesion; Elestat; E... |